Cost Action- CA: 15135: Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig) (2017-2020)
TUBITAK 1001: Phosphorylation-Independent Activation of Arrestin by Means of Small Molecules and In-vitro Characterization(2018-2021)
In silico determination of short–lived conformational ensemble and allosteric interaction mechanism, which emerge upon binding of pharmacologically different ligands to G protein-coupled receptors by means of experimental phi-values (2019-2021)
TUBITAK 2209-A: Modulating intrinsic GTPase activity of RAS proteins by means of small molecules and their in vitro characterizations (2018-2019)
